Shingo Sakashita Selected Research

Shingo Sakashita Research Topics

Disease

34	Neoplasms (Cancer) 04/2022 - 09/2009
16	Adenocarcinoma of Lung 04/2022 - 09/2009
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2021 - 10/2014
7	Adenocarcinoma 01/2022 - 10/2011
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 12/2013
3	Carcinoma (Carcinomatosis) 01/2019 - 03/2011
2	Lung Neoplasms (Lung Cancer) 04/2021 - 10/2018
2	Alcoholic Fatty Liver 03/2021 - 01/2018
2	Hemorrhage 05/2019 - 01/2012
2	Neuroendocrine Carcinoma 04/2019 - 10/2011
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2019 - 10/2011
2	Fibrosis (Cirrhosis) 03/2019 - 01/2018
1	Residual Neoplasm 04/2022
1	Triple Negative Breast Neoplasms 04/2022
1	Rectal Neoplasms (Rectal Cancer) 04/2022
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 02/2022
1	Rheumatoid Arthritis 01/2022
1	Esophageal Squamous Cell Carcinoma 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Nervous System Diseases (Neurological Disorders) 12/2021
1	Alexander Disease (Alexander's Disease) 12/2021
1	Extranodal Extension 12/2021
1	Abdominal Aortic Aneurysm 03/2021
1	Hepatocellular Carcinoma (Hepatoma) 03/2021
1	Disease Progression 04/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Rhabdomyosarcoma 01/2020
1	Abdominal Pain (Pain, Abdominal) 05/2019
1	Polycystic liver disease 05/2019
1	Cysts 05/2019
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2019
1	Ovarian Neoplasms (Ovarian Cancer) 11/2018
1	Ewing Sarcoma (Sarcoma, Ewing) 09/2018
1	Insulin Resistance 01/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 02/2019 - 03/2014
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2011
4	RNA (Ribonucleic Acid)IBA 01/2022 - 03/2014
4	ProteomeIBA 01/2022 - 03/2014
4	ErbB Receptors (EGF Receptor)IBA 12/2021 - 08/2015
4	Formaldehyde (Formol)FDA Link 10/2018 - 09/2009
3	AntibodiesIBA 04/2022 - 02/2022
3	PlatinumIBA 01/2022 - 06/2015
3	CollagenIBA 04/2020 - 10/2014
3	ParaffinIBA 10/2018 - 09/2009
2	Cetuximab (Erbitux)FDA Link 02/2022 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 02/2019
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 04/2019
2	PhosphotyrosineIBA 01/2022 - 02/2017
2	Pharmaceutical PreparationsIBA 11/2021 - 01/2018
2	Carrier Proteins (Binding Protein)IBA 01/2019 - 03/2017
2	AntigensIBA 11/2018 - 10/2011
2	Ubiquitin-Specific ProteasesIBA 10/2018 - 06/2017
2	Phosphotransferases (Kinase)IBA 10/2018 - 01/2016
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2017 - 05/2016
2	GSK 1363089IBA 09/2017 - 01/2017
2	Immunoglobulins (Immunoglobulin)IBA 03/2017 - 03/2011
2	Tyrosine Kinase InhibitorsIBA 01/2016 - 08/2015
1	Aldehyde Dehydrogenase 1 FamilyIBA 04/2022
1	Mucin-1 (CA 15-3 Antigen)IBA 04/2022
1	Coloring Agents (Dyes)IBA 02/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	Fluorouracil (Carac)FDA LinkGeneric 01/2022
1	RNA Splice SitesIBA 12/2021
1	Glial Fibrillary Acidic ProteinIBA 12/2021
1	Polycomb Repressive Complex 2IBA 04/2021
1	histone H3 trimethyl Lys4IBA 04/2021
1	Liver X ReceptorsIBA 03/2021
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 04/2020
1	MucinsIBA 10/2019
1	Etoposide (VP 16)FDA LinkGeneric 04/2019
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 04/2019
1	NestinIBA 03/2019
1	TicagrelorIBA 01/2019
1	CMP- N- acetylneuraminate- poly- alpha- 2,8- sialosyl sialyltransferaseIBA 01/2019
1	Aprepitant (Emend)FDA Link 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2019
1	tyrosine receptor (receptor, tyrosine)IBA 10/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Insulin (Novolin)FDA Link 01/2018
1	LectinsIBA 01/2018
1	Drug CarriersIBA 01/2018
1	Ceruloplasmin (Ferroxidase)IBA 01/2018
1	Polysaccharides (Glycans)IBA 01/2018
1	copper-binding proteinIBA 01/2018

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 01/2022 - 10/2013
4	Adjuvant Chemotherapy 12/2021 - 06/2015
3	Therapeutics 01/2020 - 08/2015
2	Lasers (Laser) 02/2022 - 04/2021
2	Proton Therapy 01/2020 - 09/2018
2	Hepatectomy 05/2019 - 01/2016
1	Neoadjuvant Therapy 04/2022
1	Esophagectomy 01/2022
1	Endovascular Aneurysm Repair 03/2021
1	Salpingo-oophorectomy 04/2020
1	Radiotherapy 01/2020
1	Nephrectomy 05/2019
1	Oral Administration 01/2019
1	Patient Transfer (Patient Dumping) 09/2018